El Salvador Becomes Malaria-free

In News: El Salvador has officially been declared malaria-free by the World Health Organization (WHO) after no reports of new indigenous cases of the disease since 2017.

  • The country is the first in Central America to achieve the WHO’s malaria-free certification status and third in the Americas overall after Argentina in 2019 and Paraguay in 2018.
  • Around half of the world’s population is at risk of malaria, particularly those living in lower-income countries and in the Americas, 765,000 cases were reported in 2018.
    • Countries like El Salvador “are living proof and inspiration” for all.
    • Despite the Corona Pandemic, El Salvador maintained Zero Malaria Cases.

Malaria Free Status

  • Globally, 38 countries and territories have achieved malaria-free status.
  • It is a WHO certification for which countries can apply for when there have been no local cases for three consecutive years.
  • India is yet to attain Malaria free status.
    • India has a target to eliminate Malaria by 2030.
  • Certification is different from elimination.
    • A country can only be certified, if it has proven beyond reasonable doubt that it has had zero local malaria transmission for three years or more.
    • Eg. China has had no indigenous malaria cases for the third year and has also made the formal request for certification.
    • In 2019, Belize and Cabo Verde reported zero indigenous malaria cases for the first time since 2000.

Global Picture

  • Malaria is one of the world’s leading killers, with more than 200 million cases and over 400,000 deaths each year, despite being preventable and curable if diagnosed early.
  • It also takes its economic toll, cutting economic growth rates by as much as 1.3 per cent in countries with high burden rates, according to WHO figures.
  • But good news is continuous shrinkage of the malaria map.
    • For instance, in 2015, the World Health Assembly adopted the global technical strategy for malaria, with milestones for 2020, 2025 and 2030.
      • The 15 year strategy set a target to reduce the global malaria cases and mortality rates by at least 90 per cent by 2030.
    • According to the World Malaria Report 2020, 1.5 billion malaria cases and 7.6 million malaria-related deaths have been averted since the year 2000.

Local, regional and global collaboration

  • E-2020: Group of 21 countries identified in 2016 that had potential to eliminate malaria by 2020.
    • El Salvador worked hard as its member despite the financial crunch.
    • The country deployed a community-based approach, complemented by collaboration with neighbouring countries to help prevent malaria from crossing country borders
  • New country-driven approach  titled “High burden to high impact” was launched by WHO in countries where malaria cases increased in 2018 as compared to 2017.

Indian Initiatives

  • National Framework for Malaria Elimination 2016: It was framed by India on the lines of Global Technical Strategy for Malaria, 2016-2030 of WHO.
  • National Strategic Plan for Malaria Elimination (NSPME) (2017-22): Based on the National Framework, India launched a plan for malaria elimination.
    • It gives year wise elimination targets in various parts of the country depending upon the endemicity of malaria in the next 5 years.
  • Malaria Elimination Research Alliance, India (MERA-India): It was established by Indian Council of Medical Research (ICMR).
    • It is a conglomeration of partners working on malaria control.
  • Odisha’s Durgama Anchalare Malaria Nirakaran (DAMaN) Initiative:  Aims to deliver services to the most inaccessible and hardest hit people of the State.
    • The initiative has in-built innovative strategies to combat asymptomatic malaria.

About Malaria

  • Causal organism: Plasmodium (Protozoa).
  • Vector: infected female Anopheles mosquitoes
  • World Malaria Day: 25th April.
  • WHO officially endorses disease-specific global awareness days for only four diseases viz. HIV-AIDS, TB, Malaria, and Hepatitis.
  • World first malaria vaccine has been rolled out in Malawi for children under two.
    • RTS,S/AS01, trade name Mosquirix, is an injectable vaccine targeting P. falciparum, the most prevalent malaria strain in Africa.
    • It is the first and only vaccine to show partial protection in young children.
    • In clinical trials, the vaccine was found to prevent approximately 4 in 10 malaria cases, including 3 in 10 cases of life-threatening severe malaria.

Source: DTE